Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1993-9-14
|
pubmed:abstractText |
Multicellular spheroids, derived from murine B16 melanoma cells, showed unique growth characteristics: when they reached about 500 microns in diameter, their morphology changed rapidly and they became amoeba-like irregular-shaped aggregates. This morphological characteristic closely resembled that of invasive cancer, and may serve as a model for local invasion. To test the possibility that the changes mentioned above can be inhibited by a drug, spheroids were treated with 0.8 microgram/ml of doxorubicin for one hour and their morphology was observed temporally. Although this concentration of the drug decreased the survival of the melanoma cells in monolayer to about 10(-3), the growth was not delayed nor were the "invasion"-like changes inhibited in the spheroids. We believe this system of multicellular spheroids is a useful model to study the mechanisms of tumour invasion, although doxorubicin could not inhibit "invasion"-like changes in this system.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0250-7005
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1215-7
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8352546-Animals,
pubmed-meshheading:8352546-Cell Aggregation,
pubmed-meshheading:8352546-Cell Division,
pubmed-meshheading:8352546-Doxorubicin,
pubmed-meshheading:8352546-Kinetics,
pubmed-meshheading:8352546-Melanoma, Experimental,
pubmed-meshheading:8352546-Mice,
pubmed-meshheading:8352546-Mice, Inbred C57BL,
pubmed-meshheading:8352546-Neoplasm Invasiveness,
pubmed-meshheading:8352546-Time Factors,
pubmed-meshheading:8352546-Tumor Cells, Cultured
|
pubmed:articleTitle |
Growth characteristics of murine B16 melanoma multicellular spheroids: a model for invasion and effects of doxorubicin treatments.
|
pubmed:affiliation |
Second Department of Pathology, Gifu University School of Medicine, Japan.
|
pubmed:publicationType |
Journal Article
|